• Investor Centre
    • Live Investor Briefing
    • Share Price and Announcements
    • Corporate Governance
  • About Us
  • News & media
    • Webcast Replays
      • Wellnex Life Q&A update with Zack Bozinovski
      • Unlocking the over-the-counter medicinal cannabis opportunity
  • Contact
  • Investor Centre
    • Live Investor Briefing
    • Share Price and Announcements
    • Corporate Governance
  • About Us
  • News & media
    • Webcast Replays
      • Wellnex Life Q&A update with Zack Bozinovski
      • Unlocking the over-the-counter medicinal cannabis opportunity
  • Contact
Wellnex-Life-ASX-WNX-medicinal-cannabis-Special-Access-Scheme-Category-B-SAS-B-Chemist-Warehouse-OneLife-Botanicals

Wellnex Life to launch medicinal cannabis products into emerging SAS-B market with Chemist Warehouse

Customer-focused healthcare company Wellnex Life (ASX: WNX) has unveiled plans to launch medicinal cannabis products into Australia’s...

2023-03-14-WNX-768x432

Wellnex Life joins forces with Chemist Warehouse to enter SAS-B medicinal cannabis market

Wellnex Life will launch five new medicinal cannabis products with leading pharmacy retailer Chemist Warehouse...

WNX-640x360

Wellnex Life completes first delivery of Pharmacy Own products to leading pharmacy distributor CH2

Wellnex Life will gain immediate national distribution for its Pharmacy Own products through a joint...

Wellnex-Life-ASX-WNX-Pharmacy-Own-CH2-Clifford-Hallam-Healthcare

Wellnex Life delivers first batch of Pharmacy Own products to exclusive distributor

Health and wellness company Wellnex Life (ASX: WNX) has delivered the first batch of its Pharmacy Own...

WNX-640x360

Off to a good start: Wellnex Life records 54% revenue increase in H1 FY23

Wellnex Life is starting 2023 on a high with a strong H1 FY23 result, product...

WNX-Mr.Bright-640x360

BIG Smiles as Wellnex Life finalises Mr. Bright deal

Wellnex Life has finalised a key acquisition as it looks to build on its strengthening...

inreview

Year in Review: Wellnex Life (ASX:WNX) with Executive Director and CEO, George Karafotias

Stockhead’s Year in Review video series is a yearly wrap up address from company leaders...

WNX-pic-768x432

Stellar start to FY23 for Wellnex with revenue up by 60%

Health and wellness company Wellnex Life (ASX:WNX) is kicking away from the main peloton of the ASX...

36412-wnx-1280x720-800x430

Wellnex Life sees innovation and cannabis as organic growth drivers in health and wellness

Wellnex Life Ltd (ASX:WNX) CEO George Karafotias speaks to Proactive about Wellnex's strategy for growth in...

GettyImages-173033817-640x360

Wholesome margins await as Wellnex e-platform, brand launch muscles into untapped online riches

Aussie-listed Wellnex is breaking open the B2C market for the first time with an e-commerce...

Posts pagination

Previous 1 2 3 4 … 15 Next
RECENT POSTS
  • Wellnex Life reports record $3m in monthly sales as it pursues dual listing on LSE
  • Wellnex Life (ASX:WNX) Investor Briefing – 19th December 2024
  • Wellnex ready for dual UK listing in new year after record November sales
  • ASX wellness stocks offering calm and anxiety relief – Part 2
  • Wellnex Life (ASX:WNX) Q&A – 9th February 2024
SHARE THIS POST
  • FB
  • Insta
  • Group 23
Home
About us
Contact us
Privacy Policy




*proposed new name change for Wattle Health Australia Limited (subject to shareholder approval)

This investor centre was built by Reach Markets

©2022 Reach Markets

×

Do you qualify as a Wholesale (708) investor?

Wholesale 708 Sophisticated Investors are individuals or entities who generally qualify under Sections 708(8) and s761G(7) of the Corporations Act based on the gross income and/or net assets test verified by a qualified accountant.
  • A gross income of $250,000 or more per annum in each of the previous two financial years; or
  • Net assets of at least $2.5 million; and
  • A verified Qualified Accountant’s certificate given no more than two (2) years ago confirming the Sophisticated Investor status. Please refer to the Corporations Act: Specifically Section 708(08) and Section s761G(7)